Roche obtains FDA 510(k) Approval for Cobas
Roche’s cobas MRSA/SA Test has received 510(k) approval from the US Food and Drug Administration (FDA) for the early and […]
Tags: Antibiotic-resistant bacteria, Bacteria, Bacterial diseases, chlamydia/gonorrhea, Cobas, Head, Health/Medical/Pharmaceuticals, healthcare-associated infections, HPV, Infections, Methicillin-resistant Staphylococcus aureus, Microbiology, molecular solution, MRSA/SA infections, overall management, Paul Brown, Roche, Roche Molecular Diagnostics, Staphylococcaceae, Staphylococcus aureus, United States, US Food and Drug Administration
US panel, cancer groups discourage annual Pap test
Pap smear tests are still the best way to prevent cervical cancer, but women should not seek them every year, […]
Cervical cancer, 8 HPV types in focus
Scientists have identified the eight human papillomavirus (HPV) types responsible for more than 90% of cervical cancer cases worldwide and say they should be the targets for the next generation of vaccines.
“IT applications serve as the backbone of our operations” : Dr Sumit Dutta, General Manager – Quest Diagnostics, India
As the Vice President and General Manager of Quest Diagnostics, Dr Sumit Dutta is responsible for creating an environment of quality, integrity and success for patients, customers and employees. Today, Quest Diagnostics is one of the largest pathology laboratories in the world.
States asked to stop HPV vaccine project
The Centre has advised the state governments to suspend the human papilloma virus vaccine programme in the wake of reports of violation of ethical guidelines and exploitation during the clinical trials of the vaccine for preventing cervical cancer among women.
